Markets

Market Nav

HIKAL LTD.

  • NSE CodeHIKALEQ
  • BSE Code524735
  • ISININE475B01022
  • IndustryPharmaceuticals

Company Information

Management

Jai Hiremath

Executive Chairman

Incorporation Year

08/07/1988

Registered Address


Mumbai, Maharashtra - 400021
Tel: 022-62770299
Fax: 022-22833913

Registrar Office

MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel: 022-49186270
Fax: 49186060

Email

info@hikal.com

Website

http://www.hikal.com

Listing

BSE, MCXSX, NSE

Corporate News

Hikal Ltd. - Announcement under Regulation 30 (LODR)-...

19-Nov-2025|4:35PM

Transcript of Earnings Call for the quarter and the half year ended Septemb

Hikal Ltd. - Analysts/Institutional Investor Meet/Con...

19-Nov-2025|4:35PM

Hikal Limited has informed the Exchange about Transcript of the Earnings ca

Hikal Ltd. - Copy of Newspaper Publication

14-Nov-2025|12:03PM

Hikal Limited has informed the Exchange about Copy of Newspaper Publication

Hikal Ltd. - Analysts/Institutional Investor Meet/Con...

13-Nov-2025|7:13PM

Hikal Limited has informed the Exchange about Link of Recording of the Earn

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug92.67262.76
Aarti Drug442.104,035.05
Aarti Pharma694.006,290.92
Abbott India29,575.0062,844.81
Accent Micro308.20739.34

MF Holding

Scheme NameValue
(₹ Cr)
Holding (%)
Tata Sm..78.660.67
ICICI P..54.220.84
Tata In..9.390.71
Motilal..3.050.11
Motilal..0.020.06

Board Meetings

DatePurpose
13/11/2025Quarterly Results
07/08/2025Quarterly Results
14/05/2025Audited Results & F..
04/02/2025Quarterly Results &..
12/11/2024Quarterly Results